Company Overview of N-of-One, Inc.
N-of-One, Inc., a molecular decision support company, provides clinicians with interpretation of molecular test results. It provides disease-specific biological relevance, clinical evidence, associated therapies, and references. The company also interprets next generation sequencing (NGS) of solid and hematological tumors, circulating tumor cells and DNA, copy number analysis, and immunohistochemistry. In addition, it offers PrecisionInsights, a clinical interpretation report for 15-20 gene NGS panels, delivering concise clinical and scientific evidence for each biomarker in the context of the cancer sub type and a list of therapeutic options; and TRIALMATCH, a patient-specific clinical tria...
430 Bedford Street
Lexington, MA 02420
Founded in 2007
Key Executives for N-of-One, Inc.
Chairman and Chief Executive Officer
Founder, President, Chief Medical Officer and Director
Chief Financial Officer and Director
Vice President of Operations
Vice President, Secretary and General Counsel
Compensation as of Fiscal Year 2017.
N-of-One, Inc. Key Developments
N-of-One, Inc. Presents at BIO International Conference 2017, Jun-19-2017 through Jun-22-2017
May 25 17
N-of-One, Inc. Presents at BIO International Conference 2017, Jun-19-2017 through Jun-22-2017. Venue: San Diego Convention Center, San Diego, California, United States. Presentation Date & Speakers: Jun-20-2017, Jennifer Levin Carter, Founder, President, Chief Medical Officer and Director. Jun-21-2017, Jennifer Levin Carter, Founder, President, Chief Medical Officer and Director.
N-of-One, Inc. Appoints Rich Gray as New Vice President of Business Development
Apr 26 17
N-of-One, Inc. announced that Rich Gray has joined their team as the new Vice President of Business Development. Rich will leverage his 25 plus years of experience leading both direct and channel sales teams to further develop channel partnerships to provide clinical interpretation on a broader scale, helping more patients gain access to more treatment options at the point of care. Rich is an experienced healthcare IT veteran having served in a variety of sales, management and executive positions. Prior to joining N-of-One, Rich served in executive sales and marketing roles at such organizations as Altos Inc. the IntelliDose division of IntrinsiQ, and Medical Systems Management (now part of Optum).
Philips Teams Up with N-Of-One to Speed Up Clinical Interpretation of Cancer Genomics
Nov 11 16
Royal Philips and N-of-One, Inc. announced they are teaming up to enhance the capabilities of Philips' IntelliSpace Genomics solution. The two companies will collaborate on the clinical analysis, annotation and interpretation of oncology cases processed through Philips' new precision medicine solution for oncology. This healthcare informatics solution integrates genomic information with full patient context to empower clinicians with precision diagnostics and therapeutics, to enable them to measure the success of precision healthcare programs. Profiling tumors using genomic information is critical for complex cancer cases, yet challenges remain in rapidly and accurately interpreting genomic findings in the context of a patient's condition. While most cancer patients have thousands of gene variants and mutations, only a small number actually drive the individual's specific cancer or may have actionable therapeutic implications for a particular patient.
Similar Private Companies By Industry
Recent Private Companies Transactions
January 18, 2017